April 2025
1. PENG X, Jing X, Li T, Cheng J, et al
   Serum of interleukin-6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation.
   Cancer. 2025;131:e35835.
   

   >> Share

   
   May 2024
2. SENAPATI J, Kantarjian HM, Bazinet A, Reville P, et al
   Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
   Cancer. 2024 May 29. doi: 10.1002/cncr.35388.
   

   >> Share

   
   
3. RICHARDSON NH, Taza F, Abonour R, Althouse SK, et al
   High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience.
   Cancer. 2024 May 20. doi: 10.1002/cncr.35375.
   

   >> Share

   
   
4. BAZARBACHI AH, Labopin M, Raiola AM, Blaise D, et al
   Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Tran
   Cancer. 2024 May 17. doi: 10.1002/cncr.35365.
   

   >> Share

   
   April 2024
5. GIRI S, Harmon C, Landier W, Chen Y, et al
   Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphoma.
   Cancer. 2024 Apr 5. doi: 10.1002/cncr.35298.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share